LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $14,845,322

Key CONT_AWD_75N91018F00066_7529_HHSN261201500003I_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 79 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91018F00066_7529_HHSN261201500003I_7529

At the source https://www.usaspending.gov/award/CONT_AWD_75N91018F00066_7529_HHSN261201500003I_7529

Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:56Z

Content hash e25a4cf699c77f05802a7ef1492d5764c7640af58926717bc104080aa589abf7

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

Version	Amount	Change	Occurred	Published	Retrieved	How it arrived	Content hash
1 current	$14,845,322	first version	September 26, 2018	June 18, 2026	2026-09-05T00:54:56Z	historical sweep	`e25a4cf699c7`

Archived copy

None on file. An archived copy is optional corroboration and never a condition of this filing’s provenance, which is the stored response and its hash above; see the methodology page.

What the amount is made of

9 recorded actions, so the amount is the award's current total across all of them. 5 of them obligated money. Measured 2026-10-12, when USAspending reported a total obligation of $14,845,322.

Action date	Modification	Type	Obligated	Description as recorded
June 18, 2026	P00008	OTHER ADMINISTRATIVE ACTION	−$3,163	FY26 UDO INITIATIVE
May 19, 2023	P00007	OTHER ADMINISTRATIVE ACTION	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
December 22, 2021	P00006	OTHER ADMINISTRATIVE ACTION	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
June 25, 2021	P00005	OTHER ADMINISTRATIVE ACTION	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
May 24, 2021	P00004	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	+$465,966	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
May 26, 2020	P00003	SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE	no money	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
September 25, 2019	P00002	EXERCISE AN OPTION	+$5,897,683	ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
December 6, 2018	P00001	EXERCISE AN OPTION	+$1,043,611	IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS
September 26, 2018	base	not on file	+$7,441,225	IGF::OT::IGF ANTI-HIV BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES FOR AMP TRIALS

Last refreshed November 4, 2026 at 2:31 PM UTC.